Zevra Therapeutics, Inc. Earnings Per Share (Basic)
Zevra Therapeutics, Inc. (ZVRA) reported Earnings Per Share (Basic) of $0.14 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-05
- Zevra Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was $0.14, a 88.71% decline year-over-year.
- Zevra Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was $0.62.
- Zevra Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was $0.21.
- Zevra Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.01.
- Zevra Therapeutics, Inc. earnings per share, basic for fiscal 2025 was $1.40.
- Zevra Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$2.28.
- Zevra Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$1.30.
- Zevra Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$0.78.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.14 10-Q · filed 2026-08-05 | $0.76 10-Q · filed 2026-08-05 | $0.98 derived: net income ÷ weighted average shares · filed 2026-08-05 | $0.97 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2026-03-31 | $0.62 10-Q · filed 2026-05-06 | $0.84 derived: net income ÷ weighted average shares · filed 2026-05-06 | $0.84 derived: net income ÷ weighted average shares · filed 2026-05-06 | $2.05 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2025-12-31 | $0.21 derived: net income ÷ weighted average shares · filed 2026-03-09 | $0.20 derived: net income ÷ weighted average shares · filed 2026-03-09 | $1.42 derived: net income ÷ weighted average shares · filed 2026-08-05 | $1.40 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$0.01 10-Q · filed 2025-11-05 | $1.22 derived: net income ÷ weighted average shares · filed 2026-08-05 | $1.20 10-Q · filed 2025-11-05 | $0.52 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2025-06-30 | $1.24 10-Q · filed 2026-08-05 | $1.20 10-Q · filed 2026-08-05 | $0.54 derived: net income ÷ weighted average shares · filed 2026-08-05 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-08-05 | ||||
| 2025-03-31 | -$0.06 10-Q · filed 2026-05-06 | -$0.72 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$1.39 derived: net income ÷ weighted average shares · filed 2026-05-06 | -$1.87 derived: net income ÷ weighted average shares · filed 2026-05-06 | ||||
| 2024-12-31 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$1.36 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$1.86 derived: net income ÷ weighted average shares · filed 2026-03-09 | -$2.28 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | -$0.69 10-Q · filed 2025-11-05 | -$1.18 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$1.59 10-Q · filed 2025-11-05 | -$2.11 derived: net income ÷ weighted average shares · filed 2025-11-05 | ||||
| 2024-06-30 | -$0.48 10-Q · filed 2025-08-12 | -$0.87 10-Q · filed 2025-08-12 | -$1.38 derived: net income ÷ weighted average shares · filed 2025-08-12 | -$1.70 derived: net income ÷ weighted average shares · filed 2025-08-12 | ||||
| 2024-03-31 | -$0.40 10-Q · filed 2025-05-13 | -$0.91 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$1.22 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$1.33 derived: net income ÷ weighted average shares · filed 2025-05-13 | ||||
| 2023-12-31 | -$0.51 derived: net income ÷ weighted average shares · filed 2025-03-12 | -$0.82 derived: net income ÷ weighted average shares · filed 2025-03-12 | -$0.92 derived: net income ÷ weighted average shares · filed 2025-03-12 | -$1.30 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | -$0.30 10-Q · filed 2024-11-13 | -$0.40 10-Q · filed 2023-11-07 | -$0.38 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.76 10-Q · filed 2024-11-13 | -$0.90 10-Q · filed 2023-11-07 | -$0.59 derived: net income ÷ weighted average shares · filed 2024-11-13 | ||
| 2023-06-30 | -$0.08 10-Q · filed 2024-08-14 | -$0.15 10-Q · filed 2023-08-14 | -$0.46 10-Q · filed 2024-08-14 | -$0.49 10-Q · filed 2023-08-14 | -$0.29 derived: net income ÷ weighted average shares · filed 2024-08-14 | -$0.49 derived: net income ÷ weighted average shares · filed 2024-08-14 | ||
| 2023-03-31 | -$0.38 10-Q · filed 2024-05-09 | -$0.34 10-Q · filed 2023-05-15 | -$0.22 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$0.41 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$1.11 derived: net income ÷ weighted average shares · filed 2024-05-09 | |||
| 2022-12-31 | $0.17 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$0.03 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$0.72 derived: net income ÷ weighted average shares · filed 2024-04-01 | -$0.78 10-K · filed 2024-04-01 | -$1.20 10-K · filed 2023-03-07 | |||
| 2022-09-30 | -$0.19 10-Q · filed 2023-11-07 | -$0.89 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$0.94 10-Q · filed 2023-11-07 | -$1.02 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2022-06-30 | -$0.70 10-Q · filed 2023-08-14 | -$0.75 10-Q · filed 2023-08-14 | -$0.82 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$0.87 derived: net income ÷ weighted average shares · filed 2023-08-14 | ||||
| 2022-03-31 | -$0.05 10-Q · filed 2023-05-15 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$0.18 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$0.51 derived: net income ÷ weighted average shares · filed 2023-05-15 | ||||
| 2021-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2023-03-07 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-03-07 | -$0.46 derived: net income ÷ weighted average shares · filed 2023-03-07 | -$2.11 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | -$0.05 10-Q · filed 2022-11-10 | -$0.39 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$2.16 10-Q · filed 2022-11-10 | -$2.95 derived: net income ÷ weighted average shares · filed 2022-11-10 | ||||
| 2021-06-30 | -$0.40 10-Q · filed 2022-08-12 | -$2.42 10-Q · filed 2022-08-12 | -$3.59 derived: net income ÷ weighted average shares · filed 2022-08-12 | -$4.63 derived: net income ÷ weighted average shares · filed 2022-08-12 | ||||
| 2021-03-31 | -$2.49 10-Q · filed 2022-05-12 | -$0.54 10-Q · filed 2021-05-14 | -$4.44 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$5.93 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$6.83 derived: net income ÷ weighted average shares · filed 2022-05-12 | |||
| 2020-12-31 | -$1.07 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$1.75 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$1.63 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$3.21 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | -$0.68 10-Q · filed 2021-11-10 | -$0.04 10-Q · filed 2020-10-30 | -$0.51 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$2.08 10-Q · filed 2021-11-10 | -$0.13 10-Q · filed 2020-10-30 | |||
| 2020-06-30 | $0.21 10-Q · filed 2021-08-13 | $0.01 10-Q · filed 2020-08-12 | -$1.41 10-Q · filed 2021-08-13 | -$0.09 10-Q · filed 2020-08-12 | ||||
| 2020-03-31 | -$1.92 10-Q · filed 2021-05-14 | |||||||
| 2019-09-30 | $0.09 10-Q · filed 2020-10-30 | -$0.65 10-Q · filed 2020-10-30 | ||||||
| 2019-06-30 | -$0.33 10-Q · filed 2020-08-12 | -$0.78 10-Q · filed 2020-08-12 | ||||||
| 2018-09-30 | -$0.94 10-Q · filed 2019-11-14 | -$3.33 10-Q · filed 2019-11-14 | ||||||
| 2018-06-30 | -$0.65 10-Q · filed 2019-08-13 | -$2.41 10-Q · filed 2019-08-13 | ||||||
| 2017-12-31 | -$0.72 10-K · filed 2018-03-30 | |||||||
| 2017-09-30 | -$0.68 10-K · filed 2018-03-30 | |||||||
| 2017-06-30 | -$0.44 10-Q · filed 2018-08-10 | -$1.56 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | -$1.11 10-K · filed 2018-03-30 | |||||||
| 2016-12-31 | -$0.68 10-K · filed 2018-03-30 | |||||||
| 2016-09-30 | -$0.92 10-K · filed 2018-03-30 | |||||||
| 2016-06-30 | $0.59 10-K · filed 2018-03-30 | $0.41 10-Q · filed 2017-08-10 | ||||||
| 2016-03-31 | -$0.20 10-K · filed 2018-03-30 | |||||||
| 2015-12-31 | -$0.64 10-K · filed 2017-03-10 | |||||||
| 2015-09-30 | -$0.68 10-K · filed 2017-03-10 | |||||||
| 2015-06-30 | -$2.45 10-K · filed 2017-03-10 | -$4.91 10-Q · filed 2016-08-11 | ||||||
| 2015-03-31 | -$2.50 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |